(Q38468028)

3 September 2017

title

p21(WAF1) expression and endocrine response in breast cancer (English)

1 reference

3 September 2017

6

Ellis IO

1 reference

3 September 2017

2

Gee JM

1 reference

3 September 2017

McClelland RA

1

1 reference

3 September 2017

O'Sullivan L

3

1 reference

3 September 2017

Barnes DM

4

1 reference

3 September 2017

Robertson JF

5

1 reference

3 September 2017

Nicholson RI

7

1 reference

3 September 2017

publication date

1 June 1999

1 reference

3 September 2017

1 reference

3 September 2017

volume

188

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

126-132

1 reference

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199906%29188%3A2%3C126%3A%3AAID-PATH340%3E3.0.CO%3B2-O

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199906%29188%3A2%3C126%3A%3AAID-PATH340%3E3.0.CO%3B2-O

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199906%29188%3A2%3C126%3A%3AAID-PATH340%3E3.0.CO%3B2-O

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199906%29188%3A2%3C126%3A%3AAID-PATH340%3E3.0.CO%3B2-O

10.1002/(SICI)1096-9896(199906)188:2<126::AID-PATH340>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference